Monday, 9 July 2018

CTI Biopharma's cancer drug fails late-stage trial

CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)